Michael Kram

743 total citations
12 papers, 563 citations indexed

About

Michael Kram is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Michael Kram has authored 12 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Michael Kram's work include Liver Disease Diagnosis and Treatment (3 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Michael Kram is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Michael Kram collaborates with scholars based in United States. Michael Kram's co-authors include Jayanta Roy Chowdhury, Albert D. Moscioni, Jay H. Lefkowitch, David Feldman, Stanley Μ. Levenson, Achilles A. Demetriou, Namita Roy Chowdhury, James F. Whiting, Stephen I. Goodman and Daniel C. Cohen and has published in prestigious journals such as Science, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

Michael Kram

12 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kram United States 9 260 159 124 78 71 12 563
Akinari Tabaru Japan 15 226 0.9× 177 1.1× 92 0.7× 221 2.8× 81 1.1× 52 641
Yoshihiro Kanbara Japan 13 111 0.4× 297 1.9× 144 1.2× 436 5.6× 119 1.7× 30 739
Liliana Zaidel Israel 12 126 0.5× 122 0.8× 76 0.6× 118 1.5× 42 0.6× 28 479
Noriko Fujita Japan 10 208 0.8× 23 0.1× 111 0.9× 65 0.8× 42 0.6× 13 469
M. Siciliano Italy 8 168 0.6× 343 2.2× 70 0.6× 256 3.3× 27 0.4× 13 584
Nikalesh Ippagunta United States 8 122 0.5× 67 0.4× 111 0.9× 103 1.3× 80 1.1× 8 558
Peter J. Mackrell United States 12 200 0.8× 38 0.2× 104 0.8× 60 0.8× 21 0.3× 16 588
E. Alt United States 11 233 0.9× 135 0.8× 235 1.9× 220 2.8× 156 2.2× 24 810
Karolina Kędzierska Poland 11 143 0.6× 27 0.2× 86 0.7× 43 0.6× 56 0.8× 53 467
Florencia Vargas Mexico 10 172 0.7× 317 2.0× 69 0.6× 342 4.4× 26 0.4× 16 599

Countries citing papers authored by Michael Kram

Since Specialization
Citations

This map shows the geographic impact of Michael Kram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kram more than expected).

Fields of papers citing papers by Michael Kram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kram. The network helps show where Michael Kram may publish in the future.

Co-authorship network of co-authors of Michael Kram

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kram. A scholar is included among the top collaborators of Michael Kram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kram. Michael Kram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kram, Michael. (2023). Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis. World Journal of Hepatology. 15(2). 201–207. 20 indexed citations
2.
Kram, Michael, et al.. (2003). Behçet's Ileocolitis: Successful Treatment With Tumor Necrosis Factor-Alpha Antibody (Infliximab) Therapy. Diseases of the Colon & Rectum. 46(1). 118–121. 48 indexed citations
3.
Kram, Michael, et al.. (2002). Lymphoplasmacytic sclerosing pancreatitis and cholangitis. Gastrointestinal Endoscopy. 55(4). 588–590. 17 indexed citations
4.
Kram, Michael, et al.. (2002). Hemorrhagic colitis caused by amyloid. Gastrointestinal Endoscopy. 56(4). 564–565. 1 indexed citations
5.
Lefkowitch, Jay H., et al.. (2002). Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone Therapy. Annals of Internal Medicine. 136(6). 449–452. 122 indexed citations
6.
Kram, Michael, Lyall A. Gorenstein, David Eisen, & Daniel C. Cohen. (2000). Acute esophageal necrosis associated with gastric volvulus. Gastrointestinal Endoscopy. 51(5). 610–612. 34 indexed citations
7.
Kram, Michael, et al.. (1988). Colonoscopic findings in a leukemic patient. Gastrointestinal Endoscopy. 34(1). 59–61. 1 indexed citations
8.
Kram, Michael, et al.. (1988). Turner's syndrome and inflammatory bowel disease: a case report with immunologic studies.. PubMed. 83(11). 1294–7. 19 indexed citations
9.
Chowdhury, N R, F. Gross, Albert D. Moscioni, et al.. (1987). Isolation of multiple normal and functionally defective forms of uridine diphosphate-glucuronosyltransferase from inbred Gunn rats.. Journal of Clinical Investigation. 79(2). 327–334. 23 indexed citations
10.
Demetriou, Achilles A., James F. Whiting, David Feldman, et al.. (1986). Replacement of Liver Function in Rats by Transplantation of Microcarrier-Attached Hepatocytes. Science. 233(4769). 1190–1192. 234 indexed citations
11.
Frishman, William H., Joel A. Strom, Marc W. Kirschner, et al.. (1981). Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade. The American Journal of Cardiology. 48(5). 917–928. 41 indexed citations
12.
Frishman, William H., Marc W. Kirschner, Joel A. Strom, et al.. (1981). Labetalol therapy in angina pectoris and systemic hypertension: Effects of combined alpha-beta adrenergic block-ade. The American Journal of Cardiology. 47. 430–430. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026